Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oncolytics Biotech Q2 EPS $(0.13) Up From $(0.17) YoY

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.13) per share. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year.
byBenzinga Newsdesk
August 6, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.13) per share. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Yamana Gold: Q4 Earnings Insights

By Benzinga Insights
Today, 8:35 AM
Yamana Gold (NYSE:AUY) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Yamana Gold beat estimated earnings by 22.22%, reporting an EPS of $0.11 versus an estimate of $0.09.

AUY